ArticleCancers2025

Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma.

Emeline Tabouret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.